Home / News / India News / Article /
Govt panel recommends EUA for BE's Covid-19 jab Corbevax for 12-18 yrs age group
Updated On: 14 February, 2022 09:35 PM IST | New Delhi | PTI
The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India`s first indigenously developed RBD protein sub-unit vaccine against Covid-19, for restricted use in an emergency situation in adults on December 28. It has not been included in the country`s vaccination drive
Listen to this article :
Representative image
An expert panel of India`s central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E`s Covid-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions, official sources said.
The government has still not taken a decision on vaccinating those aged below 15 years. NITI Aayog member (Health) VK Paul at a press conference recently said that the additional need for vaccination and inclusion of population for vaccination is examined constantly. The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India`s first indigenously developed RBD protein sub-unit vaccine against Covid-19, for restricted use in an emergency situation in adults on December 28. It has not been included in the country`s vaccination drive.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT